VOYA Investment Management
CADL icon

VOYA Investment Management’s Candel Therapeutics CADL Stock Holding History

VOYA Investment Management’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Buy
+12,602
New +$95.2K ﹤0.01% 2325
2025
Q3 		– Sell
-10,981
Closed -$55.6K – 2472
2025
Q2 		$55.6K Buy
+10,981
New +$56.5K ﹤0.01% 2584

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

VOYA Investment Management's CADL Position: Q2 2026 in Review

VOYA Investment Management opened a new position in Candel Therapeutics (CADL) in Q2 2026: 12,602 shares worth $130K. The stake represents ﹤0.01% of the portfolio and ranks #2325 among its holdings. This is a return to the name: VOYA Investment Management previously reported a position in CADL as recently as Q2 2025.

VOYA Investment Management first reported a position in CADL in Q2 2025 and has held it in 2 quarters since. 137 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • VOYA Investment Management held 12,602 shares of Candel Therapeutics worth $130K as of Q2 2026.
  • Candel Therapeutics was a new VOYA Investment Management position in Q2 2026.
  • Candel Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2325 holding.
  • VOYA Investment Management first reported a position in Candel Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • 137 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.